C18:0-d7 GD2 Ceramide (d18:1/18:0-d7), synthetic A86124 (Previously 860124) C18:0-d7 GD2 Ganglioside (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4Glcb-Ceramide(d18:1/18:0-d7))
GD2 Ceramide is a promising target for cancer immunotherapy due to it being prsent in many tumor cells such as melanoma and neuorblastoma. Due to it being present in a wide variety of cancers, it is a promising tumor biomarker. This GD2 Ceramide is the deuterated version, which will enable the easier study of structure, dynamics, and function of cell membranes.